Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
Classifica tra le azioni #3309
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Prezzo delle azioni
$6.32
Capitalizzazione di mercato
$5.66B
Variazione (1 giorno)
0.30%
Variazione (1 anno)
27.31%
Paese
CN
Scambia Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Categoria

Storico del prezzo dell'azione per Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Prezzo di chiusura più alto: $6.78 il 2026-08-01

Prezzo di chiusura più basso: $4.81 il 2020-07-01
Storico del prezzo dell'azione di Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 5.66%
2025 188.76%
2024 -5.91%
2023 62.34%
2022 -30.84%
2021 -25.95%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$768.37 6.79%
CH